Analysed BIOLINERX LTD-SPONS ADR (BLRX:NASDAQ) News Sources
BioLineRx Reports First Quarter 2026 Financial Results and Provides Corporate Update
27-05-2026
yahoo.com
BioLine Rx Ltd (BLRX) Q1 2026 Earnings Call Highlights: Revenue Growth and Strategic ...
03-06-2026
yahoo.com
BioLineRx and Hemispherian Announce New Preclinical Data Demonstrating Strong Synergistic Effect between GLIX1 and PARP Inhibitor in a Patient-Derived Ovarian Cancer Xenograft Model
08-07-2026
yahoo.com
BioLineRx and Hemispherian AS to Present Data Demonstrating Strong Synergy of GLIX1 with PARP Inhibitors in HR-Proficient Ovarian Cancers at ESMO 2026
20-07-2026
yahoo.com
BioLineRx Announces $3.75 Million Registered Direct Offering and Concurrent Private Placement
28-08-2026
yahoo.com
BioLineRx Reports Second Quarter 2026 Financial Results and Provides Corporate Update
31-08-2026
yahoo.com
BioLine Rx Ltd (BLRX) (Q2 2026) Earnings Call Highlights: Advancing GLIX1 Pipeline and ...
31-08-2026
yahoo.com
What is the current price of BIOLINERX LTD-SPONS ADR (BLRX:NASDAQ)?
The current price of BIOLINERX LTD-SPONS ADR (BLRX:NASDAQ) is $2.6.
BIOLINERX LTD-SPONS ADR (BLRX:NASDAQ) absolute price change since previous trading day?
The absolute price change of BIOLINERX LTD-SPONS ADR (BLRX:NASDAQ) since the previous trading day is $0.0305.
BIOLINERX LTD-SPONS ADR (BLRX:NASDAQ) percentage price change since previous trading day?
The percentage price change of BIOLINERX LTD-SPONS ADR (BLRX:NASDAQ) since the previous trading day is 1.187%.
What is the most recent average sentiment score for BIOLINERX LTD-SPONS ADR (BLRX:NASDAQ)?
The most recent average sentiment score for BIOLINERX LTD-SPONS ADR (BLRX:NASDAQ) is 74 out of 100.
What is the most recent average sentiment for BIOLINERX LTD-SPONS ADR (BLRX:NASDAQ)?
The most recent sentiment for BIOLINERX LTD-SPONS ADR (BLRX:NASDAQ) is .
SEC-8K** Filing Available For BIOLINERX LTD-SPONS ADR (BLRX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.